Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Artron Laboratories has over 20 years of experience in developing and commercializing rapid in vitro diagnostic lateral flow tests. Their products are licensed by Health Canada (ISO 13485 certified), CE marked for Europe, and FDA registered. They have a global presence with more than 200 products developed and distributed in over 140 countries. The company’s portfolio includes rapid diagnostic kits for infectious disease screening (including combo tests like HIV/HCV/HBsAg), reproductive health/fertility testing kits (such as hCG/LH/FSH/sperm count), COVID‑19 antigen home tests, GMO/food safety assays. They also offer custom development/OEM services for lateral flow devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Artron Laboratories.